Institute of Virology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg (FAU) Erlangen, Germany.
Institute of Clinical Hygiene, Medical Microbiology and Infectiology, Paracelsus Medical University, Nuremberg, Germany.
Euro Surveill. 2020 Oct;25(39). doi: 10.2807/1560-7917.ES.2020.25.39.2001650.
We found that a single nucleotide polymorphism (SNP) in the nucleoprotein gene of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a patient interfered with detection in a widely used commercial assay. Some 0.2% of the isolates in the EpiCoV database contain this SNP. Although SARS-CoV-2 was still detected by the other probe in the assay, this underlines the necessity of targeting two independent essential regions of a pathogen for reliable detection.
我们发现,一位患者的严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)核蛋白基因中的单核苷酸多态性(SNP)干扰了一种广泛使用的商业检测。EpiCoV 数据库中约有 0.2%的分离株含有这种 SNP。尽管该检测方法仍能检测到 SARS-CoV-2 的其他探针,但这强调了为可靠检测靶向病原体两个独立必需区域的必要性。